| Literature DB >> 28878783 |
Anna Podgórska1, Maria Burian1, Bożena Szal1.
Abstract
Reactive oxygen species (ROS), by their very nature, are highly reactive, and it is no surprise that they can cause damage to organic molecules. In cells, ROS are produced as byproducts of many metabolic reactions, but plants are prepared for this ROS output. Even though extracellular ROS generation constitutes only a minor part of a cell's total ROS level, this fraction is of extraordinary importance. In an active apoplastic ROS burst, it is mainly the respiratory burst oxidases and peroxidases that are engaged, and defects of these enzymes can affect plant development and stress responses. It must be highlighted that there are also other less well-known enzymatic or non-enzymatic ROS sources. There is a need for ROS detoxification in the apoplast, and almost all cellular antioxidants are present in this space, but the activity of antioxidant enzymes and the concentration of low-mass antioxidants is very low. The low antioxidant efficiency in the apoplast allows ROS to accumulate easily, which is a condition for ROS signaling. Therefore, the apoplastic ROS/antioxidant homeostasis is actively engaged in the reception and reaction to many biotic and abiotic stresses.Entities:
Keywords: antioxidants; apoplastic reactive oxygen species; biotic and abiotic stress; detoxification; respiratory burst enzymes
Year: 2017 PMID: 28878783 PMCID: PMC5572287 DOI: 10.3389/fpls.2017.01353
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Annotation of extracellular localization of antioxidant enzymes.
| Enzyme | Agi | TAIR | SUBA4 | ePLANT |
|---|---|---|---|---|
| FSD1 | At4g25100 | Plasma membrane | Extracellular: SLP-Local; MS | Extracellular: 12 |
| FSD2 | At5g51100 | No extracellular annotation | Plasma membrane: MS | Plasma membrane : 10 |
| CSD1 | At1g08830 | No extracellular annotation | Extracellular: EpiLoc; PredSL; MS | Extracellular: 14 |
| CSD2 | At2g28190 | apoplast | Extracellular: SubLoc; MS | Extracellular: 2 |
| CSD3 | At5g18100 | No extracellular annotation | Extracellular: SubLoc; MS | Extracellular: 12 |
| MSD1 | At3g10920 | No extracellular annotation | Extracellular: MS | No extracellular annotation |
| MSD2 | At3g56350 | No extracellular annotation | extracellular: Predotar; PredSL; PProwler; iPSORT; SLP-Local; WoLF PSORT; Target P; YLoc; MS | Extracellular: 16 |
| APX1 | At1g07890 | No extracellular annotation | Extracellular: MS | Plasma membrane: 30 |
| APX2 | At3g09640 | No extracellular annotation | Extracellular: PredSL | Extracellular: 2 |
| APX3 | At4g35000 | No extracellular annotation | Extracellular: MS | Plasma membrane: 20 |
| APX6 | At4g32320 | Extracellular region | No extracellular annotation | No extracellular annotation |
| MDHAR6 | At1g63940 | No extracellular annotation | Extracellular: MS | Plasma membrane: 10 |
| MDHAR3 | At3g09940 | No extracellular annotation | Extracellular: MS | No extracellular annotation |
| MDHAR4 | At3g27820 | Integral component of membrane | Extracellular: Predotar; PredSL; PProwler; SLPFA; SLP-Local; BaCelLo; iPSORT | Extracellular: 14; |
| MDHAR1 | At3g52880 | Apoplast, plasma membrane | Extracellular: MS | Plasma membrane: 50 |
| MDHAR2 | At5g03630 | No extracellular annotation | Extracellular: MS | No extracellular annotation |
| DHAR2 | At1g75270 | Plasma membrane | Extracellular: AdaBoost; SLPFA | Extracellular: 4; |
| DHAR4 | At1g19550 | No extracellular annotation | Extracellular: SLPFA | Extracellular: 2 |
| DHAR1 | At1g19570 | Apoplast, plasma membrane | Extracellular: AdaBoost; SLPFA; MS | Extracellular:4; |
| GR1 | At3g24170 | No extracellular annotation | Extracellular: MS | No extracellular annotation |
| GR2 | At3g54660 | No extracellular annotation | Extracellular: MS | No extracellular annotation |
| CAT1 | At1g20630 | Cell wall | Extracellular: SLPFA; SubLoc | Extracellular: 4; |
| CAT2 | At4g35090 | No extracellular annotation | Extracellular: SLPFA; SubLoc; MS | Extracellular: 4 |
| CAT3 | At1g20620 | Apoplast, cell wall, plasma membrane, | Extracellular: SLPFA | Extracellular: 2 |
| GPX1 | At2g25080 | No extracellular annotation | Extracellular: MS | No extracellular annotation |
| GPX2 | At2g31570 | Plasma membrane | Extracellular: PredSL | Extracellular: 2 |
| GPX3 | At2g43350 | No extracellular annotation | Extracellular: PProwler | Extracellular: 2 |
| GPX4 | At2g48150 | No extracellular annotation | Extracellular: PredSL; | Extracellular: 4 |
| GPX5 | At3g63080 | Plasma membrane | Extracellular: PredSL | Extracellular: 2 |
| GPX8 | At1g63460 | No extracellular annotation | Extracellular: PredSL; | Extracellular: 4 |
Impact of changes in apROS-producing enzyme expression on development and metabolism of Arabidopsis plants (examples).
| Enzyme | Changes in gene expression | Developmental/metabolic effect | Reference |
|---|---|---|---|
| RBOHC | Stunted roots, short root hairs, defect in setting up the tip-high calcium gradient in root hairs | ||
| RBOHD | Smaller rosette size; enhanced accumulation coumarin and scopoletin in response to pathogen treatment; decreased accumulation of callose in response to elicitor; suppression of jasmonic acid-responsive genes; inability to mediate rapid systemic response; higher sensitivity aphid infection | ||
| RBOHF | Delayed accumulation of salicylic acid in response to pathogen treatment; decreased APX1 transcript level suppression of jasmonic acid-responsive genes | ||
| RBOHH/ RBOHJ | Reduced fertility; pollen tube collapse | ||
| POX2 or POX25 | Lower dry-weight of the main stem; decreased lignin content and altered lignin structure | ||
| POX34 | Reduced callose deposition in response to microbe-associated molecular patterns; diminished expression of flagellin-responsive genes | ||
| POX37 | Dwarfism; smaller leaf surface; delay on growth of the flower stems; reduction in root length and secondary root development; increase in phenolic compounds of cell wall | ||
| POX53 | Longer hypocotyl; increased susceptibility to nematode; three-carpel silique phenotype | ||
| POX57 | Dwarfism; increased callose deposit in response to bacterial elicitors; increased resistance to nectrotrophic pathogens and higher sensitivity to hemibiotroph pathogens; impaired cutin biosynthesis | ||
| POX 71 | Enhanced biomass; longer hypocotyls; increased cell area | ||
| Reduction of biomass; reduction of cell size | |||
| AtCuAOβ (CuAO1) | Impaired NO production; lower sensitivity to exogenous ABA; lower expression of stress-responsive genes in response to ABA treatment | ||